IFNA2 and melanoma: Balb/c nu/nu (athymic) mice bearing A375 human melanoma tumors were treated with vehicle, IFN-α-2b (2 × 104 units/day, intraperitoneal injection), ixazomib (7.0 mg/kg twice weekly, oral gavage), or IFN-α-2b and ixazomib combined.